ALT
$4.31
Altimmune
$.16
3.86%
ALT
Earnings Whisper ®
N/A
3rd Quarter September 2018
Consensus:  ($3.60)
Revenue:  $2.50 Mil
Tuesday
Nov 13
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ALT reports earnings?
Beat
Meet
Miss

Where is ALT's stock price going from here?
Up
Flat
Down
Stock chart of ALT
Analysts
Summary of analysts' recommendations for ALT
Score
Grade
Pivots
Resistance
$5.02
$4.78
$4.55

$4.31

Support
$4.08
$3.84
$3.61
Tweet
Growth
Description
Alteon Inc. is engaged in the discovery and development of new pharmaceutical products for the treatment of cardiovascular and renal diseases and other disorders of diabetes and aging. Alteon's proprietary technology focuses on Advanced Glycosylation End-products which are abnormal glucose/protein complexes that form as a result of circulating blood glucose reacting with proteins.